Advertising America Australia Biotech Canada China Chinese Currency E-Commerce Economy Facebook Guangdong Healthcare Hong Kong India Italy Macau Malaysia Manila Manufacturing Medicine New Zealand Oil Pacific Pharmaceutical
SHANGHAI, Sept. 28, 2026 /PRNewswire/ — In 2026, China’s health and nutrition industry ushers in a historic opportunity. China’s market for medicine and food homology products is projected to exceed RMB 450 billion, while the industry’s full value chain is valued at more than RMB 2 trillion. Health spending is shifting decisively from reactive treatment to proactive wellness. The year also marks the start of China’s 15th Five-Year Plan, as the national health-first development strategy moves from national policy design to broad implementation. Proactive health demand among nearly 400 million members of the “new silver generation” is accelerating, while Generation…
News Timeline:
Track the development of this news story across the Internet.